Genomic Vision (FRA:G09) Price-to-Operating-Cash-Flow : (As of Apr. 28, 2024)

View and export this data going back to 2014. Start your Free Trial

What is Genomic Vision Price-to-Operating-Cash-Flow?

As of today (2024-04-28), Genomic Vision's share price is €0.0017. Genomic Vision's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Jun. 2023 was €-0.05. Hence, Genomic Vision's Price-to-Operating-Cash-Flow Ratio for today is .

The historical rank and industry rank for Genomic Vision's Price-to-Operating-Cash-Flow or its related term are showing as below:

During the past 10 years, Genomic Vision's highest Price-to-Operating-Cash-Flow Ratio was 151.13. The lowest was 106.91. And the median was 121.60.

FRA:G09's Price-to-Operating-Cash-Flow is not ranked ^*
in the Medical Diagnostics & Research industry.
Industry Median: 20.2
* Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.

Genomic Vision's Cash Flow from Operations per share for the six months ended in Jun. 2023 was €-0.03. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Jun. 2023 was €-0.05.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 43.90% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 52.90% per year.

During the past 10 years, Genomic Vision's highest 3-Year average Operating Cash Flow per Share Growth Rate was 63.00% per year. The lowest was -19.20% per year. And the median was 46.20% per year.

Genomic Vision Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Genomic Vision's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genomic Vision Price-to-Operating-Cash-Flow Chart

Genomic Vision Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Price-to-Operating-Cash-Flow

Get a 7-Day Free Trial

Genomic Vision Semi-Annual Data
	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Price-to-Operating-Cash-Flow	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Genomic Vision's Price-to-Operating-Cash-Flow

For the Diagnostics & Research subindustry, Genomic Vision's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Genomic Vision's Price-to-Operating-Cash-Flow Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Genomic Vision's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Genomic Vision's Price-to-Operating-Cash-Flow falls into.

Genomic Vision Price-to-Operating-Cash-Flow Calculation

Genomic Vision's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio	=	Share Price	/	Cash Flow from Operations per share (TTM)
	=	0.0017	/	-0.05
	=

Genomic Vision's Share Price of today is €0.0017.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Genomic Vision's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Jun. 2023 was €-0.05.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio

Market Cap

Cash Flow from Operations

Genomic Vision Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Genomic Vision's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

Genomic Vision (FRA:G09) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Genomic Vision SA (FRA:G09) » Definitions » Price-to-Operating-Cash-Flow

Comparable Companies

Traded in Other Exchanges

N/A

Address

80-84 rue des Meuniers, Green Square, Batiment E, Bagneux, FRA, 92220

Website

http://www.genomicvision.com

Genomic Vision SA is a molecular diagnostics and technology company specialized in the development of single DNA detection tools for research and in vitro diagnostics.

Genomic Vision (FRA:G09) Headlines

No Headlines